SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-044244
Filing Date
2024-04-15
Accepted
2024-04-15 09:16:30
Documents
14
Period of Report
2024-04-15
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lbph-20240415.htm   iXBRL 8-K 45979
2 EX-99.1 lbph-ex99_1.htm EX-99.1 379
3 PDF COURTESY COPY lbph-ex99_1.pdf EX-99.1 8567906
4 GRAPHIC lbph-ex99_1s1.jpg GRAPHIC 742031
  Complete submission text file 0000950170-24-044244.txt   12904368

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT lbph-20240415.xsd EX-101.SCH 32543
17 EXTRACTED XBRL INSTANCE DOCUMENT lbph-20240415_htm.xml XML 5112
Mailing Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 619-592-9775
Longboard Pharmaceuticals, Inc. (Filer) CIK: 0001832168 (see all company filings)

IRS No.: 845009619 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40192 | Film No.: 24843286
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)